Table 3.
Cardiac evaluations performed in men with prostate cancer referred for androgen deprivation therapy.
| Investigation | All patients (n = 100) |
High FRS (n = 49) |
Intermediate FRS (n = 25) |
Low FRS (n = 1) |
|---|---|---|---|---|
| Echocardiogram | 3 | 1 (2%) | 1 (4%) | 0 |
| Exercise treadmill test | 3 | 1 | 1 | 0 |
| Positive for ischemia | 1 | 0 | 1† | 0 |
| Negative for ischemia | 2 | 1 | 0 | 0 |
| Myocardial perfusion imaging | 2 | 0 | 0 | 0 |
| Positive for ischemia | 1 | 0 | 0 | 0 |
| Negative for ischemia | 1 | 0 | 0 | 0 |
| Stress echocardiogram | 1 | 0 | 1 | 0 |
| Positive for ischemia | 0 | 0 | 0 | 0 |
| Negative for ischemia | 1 | 0 | 1† | 0 |
| Holter monitor | 1 | 1 | 0 | 0 |
| Normal | 1 | 1 | 0 | 0 |
| Abnormal | 0 | 0 | 0 | 0 |
FRS: Framingham risk score.
†One patient had evidence of ischemia on exercise treadmill testing and was subsequently referred for stress echocardiogram which showed no ischemia.